ArticleTechnology in cancer research & treatment
NeuroMorphFusion: A Neuro-Inspired Hybrid Learning Framework for Interpretable Deep Lesion Detection in IoT-Enabled Healthcare Systems.
Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IntroductionIntegrating deep learning within the Internet of Medical Things (IoMT) has revolutionized automated lesion detection in medical imaging. Yet, maintaining high diagnostic accuracy, interpretability and computational efficiency on resource-limited edge devices remains challenging. To address these gaps, we propose NeuroMorphFusion, a neuro-inspired hybrid framework that combines biologically plausible learning with mathematical modelling for interpretable and efficient lesion detection.MethodsNeuroMorphFusion integrates a lightweight ResNet18 backbone, a Spiking Neural Network (SNN) component to capture temporal dynamics, and a morphological attention mechanism that emphasizes structure-relevant regions in CT scans. The architecture employs a semi-supervised reinforcement learning strategy, where pseudo-label accuracy and the overlap between Grad-CAM visualizations and expert annotations define the reward, ensuring explainable updates under limited labelled data. Additionally, a genetic algorithm (GA) optimizes hyperparameters-learning rate, dropout rate, spiking time steps, and attention dimensionality - for domain generalization and reduced memory use. The optimization population is restricted to 20 individuals over 30 generations, converging within eight minutes on a Jetson Nano.ResultsA multi-objective optimization scheme balances lesion detection sensitivity, computational latency and explainability. Integrated SHAP and Grad-CAM visualizations enhance interpretability. Experimental evaluation on the IQ-OTHNCCD lung cancer CT dataset demonstrates that NeuroMorphFusion achieves 98.18% classification accuracy, outperforming VGG16, SqueezeNet, MobileNetV3, and ResNet18 in both transparency and efficiency.ConclusionNeuroMorphFusion effectively unites neuro-biological inspiration, mathematical interpretability, and edge-efficient computation for IoMT-based medical imaging. Its superior accuracy, explainability, and low-latency optimization highlight its potential for real-world clinical integration and scalable IoMT deployment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.